Cambient Family Office’s CME Group CME Stock Holding History

Cambient Family Office’s Portfolio CME Stock Details CME Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-925	Closed	-$273K	–	331
2026 Q1	$273K	Buy	925 +64	+7%	+$19K	0.04%	197
2025 Q4	$235K	Buy	+861	New	+$234K	0.03%	210

Other funds holding CME

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Sanders Capital West Palm Beach, Florida $99.8B AUM 47.9% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Cambient Family Office's CME Position: Q2 2026 in Review

Cambient Family Office sold out of CME Group (CME) in Q2 2026, closing a stake of 925 shares — an estimated $273K sold.

Cambient Family Office first reported a position in CME in Q4 2025 and held it in 2 quarters. The position peaked at $273K in Q1 2026. 1,710 funds tracked by Wall St. Rank hold CME as of Q2 2026.

Cambient Family Office reported no remaining CME Group position as of Q2 2026 after selling out during the quarter.
Cambient Family Office sold 925 CME Group shares in Q2 2026, an estimated $273K.
Cambient Family Office first reported a position in CME Group in Q4 2025 and held it in 2 quarters.
Cambient Family Office's CME Group position peaked at $273K in Q1 2026.
1,710 funds tracked by Wall St. Rank held CME Group as of Q2 2026.

Based on Cambient Family Office's 13F filing for Q2 2026, filed 13 Aug 2026.